Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

September 16, 2026 Antimicrobial Stewardship Forum (PHARMACISTS) (Immunizations CE)


Premier's Antimicrobial Stewardship Forum will be held on September 16, 2026 from 1 - 2 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.

Recent Developments and Updates Related to Respiratory Vaccines

Speaker: Joseph V. Etzel, PharmD, Associate Clinical Professor, College of Pharmacy and Health Sciences, St. John's University, Queens, NY

ACPE Universal Activity Number0122-0000-26-052-L06-P [0.1 CEU] [1 Contact Hr.] (Immunizations CE)

Important: When registering for a CE activity, please select the program that aligns with your profession (Pharmacist or Pharmacy Technician). Choosing the correct program is essential to ensure your CE credit is processed accurately and prevents delays in reporting to CPE Monitor.

 

Date: Sep 16, 2026 01:00 PM - 02:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Sep 16, 2026 01:10 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Requirements for CE Credit

CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.

Support/Credits

Financial support: Premier, Inc. has received no outside support for the administration of this program.

 

 

Wed, Sep 16, 2026
 

   

Objectives

  • Summarize the most recent ACIP recommendations for COVID-19, influenza, RSV, and pneumococcal vaccines, including updated schedules and newly approved formulations
  • Describe efficacy and safety data supporting updated respiratory vaccine products
  • Identify patient populations who may benefit from respiratory vaccines
  • Describe shared clinical decision-making recommendations related to respiratory vaccine administration
  • Outline counseling considerations regarding vaccine benefits, potential adverse effects, co-administration considerations, and approaches to addressing vaccine hesitancy

Speaker(s)/Author(s)

Joseph V. Etzel, Pharm.D
Associate Clinical Professor, College of Pharmacy and Health Sciences

Activity Number

0122-0000-26-052-L06-P
Date: 09/16/26
Time: 01:00 PM - 02:00 PM

CE Hours

1.00